Condensed Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash	$ 402,397
Prepaid expenses	271,762
Total Current Assets	674,159
Deferred offering costs		89,500
Marketable securities held in Trust Account	230,015,440
TOTAL ASSETS	230,689,599	89,500
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY
Current liabilities
Accounts payable and accrued expenses	357,683
Advances from related parties	870
Promissory note – related party		69,500
Total Current Liabilities	358,553	69,500
Warrant liabilities	11,544,000
Deferred underwriting commission payable	8,650,000
Total Liabilities	20,552,553	69,500
Commitments and Contingencies
Class A ordinary shares subject to possible redemption 23,000,000 and no shares at redemption value at September 30, 2021 and December 31, 2020, respectively	230,015,440
Shareholders’ (Deficit) Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding, at September 30, 2021 and December 31, 2020	575	575
Additional paid-in capital		24,425
Accumulated deficit	(19,878,969)	(5,000)
Total Shareholders’ (Deficit) Equity	(19,878,394)	20,000
TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY	$ 230,689,599	$ 89,500